While animal models based on common genetic mutations of AGS have aided in our understanding of how gene defects result in increased IFN-α signaling, these models have failed to recapitulate the neuropathology and neurological clinical hallmarks observed in patients with AGS (25). Here, IFNA1 is linked to Aicardi-Goutieres syndrome.